In today’s global economy, companies and organizations looking to protect their ideas and innovations need clear guidance, creative strategies, and a law firm with global intellectual property (IP) experience. As well as practising in the United States, Finnegan has an active IP practice in Europe. Finnegan’s European professionals have active practices at the European Patent Office (EPO), the UK Intellectual Property Office (UKIPO), the European Union Intellectual Property Office (EUIPO), and the UK courts. They also possess a keen understanding of the diversity of laws and practice among the European national systems. This knowledge of the European legal system and how it differs from that in the United States and elsewhere in the world allows Finnegan to effectively counsel its clients on a full range of IP issues and to find cohesive solutions tailored to the needs of companies with global intellectual property interests.
Finnegan established its European office in Brussels, Belgium in 1993. In November 2013, the office relocated to London, one of the main centres of IP practice in Europe, and a central location that allows us to work side-by-side with our clients. Our London-based professionals can answer clients’ questions in real-time, meet with them in person, and address all of their IP challenges. The lawyers and European patent and trade mark attorneys in our office are multicultural and multilingual, and can represent clients in matters both in Europe and the United States.
Finnegan routinely sponsors, hosts, and presents at conferences and seminars throughout Europe. Since 2010, we have hosted an annual webinar series focused on issues of particular relevance to European companies. In 2011, we introduced an annual seminar series also focused on timely relevant issues of interest to European countries.
Our attorneys are actively involved in the intellectual property law community, participating in organizations such as the Chartered Institute of Patent Attorneys (CIPA); European Patent Institute (epi); Licensing Executives Society International (LESI) and LES Benelux; German Association for the Protection of Intellectual Property (GRUR); Norwegian Industrial Property Association (NIPO); Association of Patent & Trademark Attorneys in Italian Industry (AICIPI); International Property Owners Association (IPO); International Federation of Intellectual Property Attorneys (FICPI); Association Internationale pour la Protection de la Propriete Intellectuelle (AIPPI); International Bar Association; International Chamber of Commerce, Intellectual Property Institute; and MARQUES Association of European Trademark Owners.
Our European team assists UK, European, and international clients with their European and UK design portfolios. Finnegan is able to represent applicants for design registration directly at the EUIPO and the UKIPO, and using the Hague system at WIPO.
Third party observations can be filed against any European application or patent for which proceedings are pending, including EPO oppositions and appeals. Our European patent attorneys have extensive experience in preparing and filing third party observations.
The EPO opposition procedure offers third parties an opportunity to attack a European patent centrally at the EPO for a limited period after grant.
Our European patent attorneys have have extensive experience before the EPO’s Opposition Divisions and various Boards of Appeal.
Our London team drafts, files, and prosecutes patent applications at the EPO and UKIPO, and also under the PCT.
SPCs can extend patent protection of human and veterinary medicines and plant protection products, including herbicides and insecticides, by up to five and a half years. Finnegan's European attorneys are experienced in handling filings and successfully obtaining SPCs in the UK and across Europe.
Our European team assists UK, European, and international clients with their European and UK trade mark portfolios. Finnegan is able to represent applicants for trade mark registration directly at the EUIPO and the UKIPO and using the Madrid system at WIPO.
Although the EPO is responsible for granting the majority of patents that are in force in the United Kingdom, the UKIPO offers a number of services that are not provided by the EPO. Finnegan's European attorneys are fully qualified UK patent attorneys, and also include Higher Court patent attorney litigators entitled to conduct litigation in the UK courts.
Finnegan prepared and prosecuted patents for startup Hutchison Medipharma in the United States for the treatment of metastatic colorectal cancer. Those patents cover a small molecule, fruquintinib, which received approval in China.
EPO
3:16-cv-06209, N.D. Cal., Judge Tigar
Conference
1st Virtual Cambridge Information and Intellectual Property Meeting
January 20-21, 2021
Virtual
Webinar
Optimizing Enforceable Patent Claim Scope, Minimizing Costs for Global Patent Portfolios
January 19, 2021
Webinar
Conference
2020 Shanghai International Trade IPR Service Center Expert Summary Conference
December 20, 2020
Shanghai
Webinar
Standing to Sue: Lessons from Recent Cases Involving Patent Assignment, Licenses, and Ownership
December 17, 2020
Webinar
Webinar
Patenting Pharmaceutical Drug Formulations: Withstanding Litigation and PTAB Challenges
February 16, 2021
Webinar
Press Release
Ten Finnegan Attorneys Named “Leading Trademark Professionals” by World Trademark Review
February 13, 2020
Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.